Moreover, a GAS6-neutralizing antibody prevents the ability of MSCs-derived soluble factors to sustain MM survival by suppressing the NF-κB signaling pathway and IL-6 expression [36]. The gene discussed is GAS6; the disease is Miyoshi myopathy.